Lymphocyte Therapy in Treating Patients With Kidney Cancer

Status unconfirmed · Phase 2

Conditions studied: Kidney Cancer

In brief

RATIONALE: Treating a person's lymphocytes with interleukin-2 and monoclonal antibody may help them kill more cancer cells when they are put back in the body. PURPOSE: This phase II trial is studying how well lymphocyte therapy works in treating patients with stage III or stage IV kidney cancer.

Key facts

Study ID

NCT00002589

Run by

National Cancer Institute (NCI)

People needed

90

Starts

1994-07-01

Last updated by the study team

2013-12-18

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.